ストップコックの世界市場：規模、シェア、動向分析（2024年～2030年）：MedCore

2023年、世界のストップコックの市場規模は1億7,510万米ドルに達し、2022年の1億6,570万米ドルと比較して5.7%増加しました。今後の予測では、年間平均成長率（CAGR）は4.9％で、最終的には2億4,550万米ドルに達する見込みです。現在、世界のストップコック市場はBecton Dickinson（BD）とB. Braunが独占しています。

ストップコックは、市場で代替技術として認知されつつある新興のニードルレスコネクターとの競争に遭遇しています。ニードルレスコネクターは、感染管理の改善、輸液の無駄の削減、輸液管理の精度向上など様々な利点を提供します。これらのコネクターはますます身近になり、採用されるようになってきており、従来のストップコック市場のセグメントに影響を与えています。ニードルレスコネクターの人気が高まるにつれ、特定の用途やヘルスケア環境において、従来のストップコックに取って代わりつつあります。

2023年、Becton Dickinson（BD）が世界のストップコック市場で不動の首位に立ち、業界における支配的地位を固めました。BDは2つの重要な製品を提供しています。BDの圧倒的な影響力は、市場シェア第2位の北米と西欧だけでなく、世界中の多くの地域市場にも及んでいます。

同年、B. Braunは世界のストップコック分野で2番目に影響力のある競争相手としての地位を確保しました。輸液ポンプ製造の専門家として有名なB. Braunは、ストップコック装置を他の医療機器とバンドルするという独自のアプローチを採用しています。多くの病院は包括的な調達アプローチを好み、輸液製品の大半を単一のメーカーから調達することを選択します。この戦略的優位性は、ストップコック市場におけるB. Braunの地位を著しく高め、特に西欧では、多様な医療機器において一貫して優れた業績を上げています。

当レポートでは、世界のストップコック市場について調査し、市場の概要とともに、セグメント別、地域別動向、競合情勢などを提供しています。

目次

ストップコック市場

• エグゼクティブサマリー
• イントロダクション
• 市場分析と予測
• 促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 競合市場シェア分析

LIST OF CHARTS

• Chart 10-1: Stopcock Market, Global, 2023 & 2030
• Chart 10-2: Stopcock Units Sold, Global, 2023
• Chart 10-3: Stopcock Market, Global, 2020 - 2030
• Chart 10-4: Leading Competitors, Stopcock Market, Global, 2023

LIST OF FIGURES

• Figure 10-1: Stopcock Regions Covered, Global (1 of 2)
• Figure 10-2: Stopcock Regions Covered, Global (2 of 2)
• Figure 10-3: Stopcock Market, Global, 2020 - 2030
• Figure 10-4: Units Sold by Region, Stopcock Market, Global, 2020 - 2030
• Figure 10-5: Average Selling Price by Region, Stopcock Market, Global, 2020 - 2030 (US$)
• Figure 10-6: Market Value by Region, Stopcock Market, Global, 2020 - 2030 (US$M)
• Figure 10-7: Leading Competitors, Stopcock Market, Global, 2023

In 2023, the worldwide stopcock market achieved a total valuation of $175.1 million, reflecting a 5.7% increase compared to the $165.7 million recorded in 2022. Projections for the upcoming period suggest a sustained growth trajectory, with a compound annual growth rate (CAGR) of 4.9%, ultimately reaching $245.5 million. Presently, the global stopcock market is under the dominance of Becton Dickinson (BD) and B. Braun.

Our comprehensive medical market research involved a thorough analysis of more than 20 stopcock companies across seven continents. Employing a rigorous methodology, we delved into market sizes, unit sales, company market shares, and generated precise forecasts.

DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Value & Growth Trends

• Forecasts Until 2030, and Historical Data to 2020

• Market Drivers & Limiters for Each Segment

• Competitive Analysis with Market Shares for Each Segment

• Recent Mergers & Acquisitions

• COVID19 Impact

• Disease Overviews and Demographic Information

• Company Profiles, Product Portfolios and SWOT for Top Competitors

GLOBAL STOPCOCK MARKET INSIGHTS

Stopcocks are encountering competition from emerging needleless connectors, which are gaining recognition as alternative technologies in the market. Needleless connectors offer various advantages, such as improved infection control, reduced fluid wastage, and enhanced precision in fluid management. These connectors are increasingly becoming more accessible and adopted, influencing traditional segments of the stopcock market. As needleless connectors continue to gain popularity, they are gradually displacing conventional stopcocks in specific applications and healthcare settings.

GLOBAL STOPCOCK MARKET SHARE INSIGHTS

In 2023, Becton Dickinson (BD) emerged as the undisputed leader in the global stopcock market, solidifying its dominant position in the industry. BD proudly offers two significant offerings: the Alaris® lipid-resistant, 3-way stopcock, and an alternative latex- and PVC-free version of this essential medical device. BD's commanding influence extends not only to North America and Western Europe, where it holds the second-largest market share, but also to numerous regional markets across the globe.

During the same year, B. Braun secured its position as the second most influential competitor in the global stopcock arena. Renowned for its expertise in infusion pump manufacturing, B. Braun adopts a distinctive approach by bundling its stopcock devices with other medical equipment. Many hospitals prefer a comprehensive sourcing approach, choosing to procure the majority of their infusion products from a single manufacturer. This strategic advantage significantly enhances B. Braun's standing in the stopcock market, particularly in Western Europe, where it consistently excels across a diverse range of medical devices.

The lower tiers of the global stopcock market landscape are predominantly occupied by smaller, localized competitors. These agile players specialize in producing straightforward, cost-effective products tailored for hospital use. Nevertheless, their market share remains modest compared to industry giants capable of bundling stopcock sales with a comprehensive suite of infusion therapy products. Notably, companies like B. Braun and Becton Dickinson, among others, reign supreme in this category, leveraging their extensive product portfolios to maintain a dominant presence.

MARKET SEGMENTATION SUMMARY

• Stopcock Market

Table of Contents

Stopcock Market

• Executive Summary
  • Global Stopcock Market Overview
  • Competitive Analysis
  • Regions Included
• Introduction
• Market Analysis and Forecast
• Drivers and Limiters
  • Market Drivers
  • Market Limiters
• Competitive Market Share Analysis